Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation.
Morimoto K, Baba Y, Shinohara H, Kang S, Nojima S, Kimura T, Ito D, Yoshida Y, Maeda Y, Sarashina-Kida H, Nishide M, Hosokawa T, Kato Y, Hayama Y, Kinehara Y, Okuno T, Takamatsu H, Hirano T, Shima Y, Narazaki M, Kurosaki T, Toyofuku T, Kumanogoh A. Morimoto K, et al. Among authors: narazaki m. Sci Rep. 2016 May 11;6:25738. doi: 10.1038/srep25738. Sci Rep. 2016. PMID: 27166870 Free PMC article.
Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial.
Kawai M, Hirano T, Arimitsu J, Higa S, Kuwahara Y, Hagihara K, Shima Y, Narazaki M, Ogata A, Koyanagi M, Kai T, Shimizu R, Moriwaki M, Suzuki Y, Ogino S, Kawase I, Tanaka T. Kawai M, et al. Among authors: narazaki m. Int Arch Allergy Immunol. 2009;149(4):359-68. doi: 10.1159/000205582. Epub 2009 Mar 17. Int Arch Allergy Immunol. 2009. PMID: 19295240 Clinical Trial.
Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis.
Hirano T, Kawai M, Arimitsu J, Ogawa M, Kuwahara Y, Hagihara K, Shima Y, Narazaki M, Ogata A, Koyanagi M, Kai T, Shimizu R, Moriwaki M, Suzuki Y, Ogino S, Kawase I, Tanaka T. Hirano T, et al. Among authors: narazaki m. Allergol Int. 2009 Sep;58(3):373-82. doi: 10.2332/allergolint.08-OA-0070. Epub 2009 May 25. Allergol Int. 2009. PMID: 19454839 Free article. Clinical Trial.
Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens.
Ogata A, Mori M, Hashimoto S, Yano Y, Fujikawa T, Kawai M, Kuwahara Y, Hirano T, Arimitsu J, Hagihara K, Shima Y, Narazaki M, Yokota S, Kishimoto T, Kawase I, Tanaka T. Ogata A, et al. Among authors: narazaki m. Mod Rheumatol. 2010 Apr;20(2):130-3. doi: 10.1007/s10165-009-0243-4. Epub 2009 Nov 7. Mod Rheumatol. 2010. PMID: 19898919
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.
Shima Y, Kuwahara Y, Murota H, Kitaba S, Kawai M, Hirano T, Arimitsu J, Narazaki M, Hagihara K, Ogata A, Katayama I, Kawase I, Kishimoto T, Tanaka T. Shima Y, et al. Among authors: narazaki m. Rheumatology (Oxford). 2010 Dec;49(12):2408-12. doi: 10.1093/rheumatology/keq275. Epub 2010 Sep 5. Rheumatology (Oxford). 2010. PMID: 20819796 Free PMC article.
Immune reconstitution inflammatory syndrome in a patient with adult-onset Still's disease: graft-versus-host-like skin reaction with possible asymptomatic human herpes virus reactivation during steroid tapering.
Yamaga K, Hanafusa T, Azukizawa H, Tanemura A, Nii T, Nishide M, Narazaki M, Katayama I. Yamaga K, et al. Among authors: narazaki m. Eur J Dermatol. 2014 Jan-Feb;24(1):101-3. doi: 10.1684/ejd.2013.2218. Eur J Dermatol. 2014. PMID: 24334185 No abstract available.
145 results